Open labelled, Randomized, Active-controlled, Parallel-arm, Single-center Study on Effect of Sitagliptin on T2DM Patients on Treatment With Metformin and Insulin.
Phase of Trial: Phase IV
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Sitagliptin (Primary) ; Glimepiride; Insulin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms SWIM
- 10 Jun 2017 Biomarkers information updated
- 09 Jun 2015 Primary endpoint has been met. (Reduction in HbA1c from baseline) as per abstract presented at 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.